Beyond Air Inc. shares are up 37% in after-hours trading Tuesday after the company said it received approval from the Food and Drug Administration for a nitric oxide generator and delivery system.
The biopharmaceutical company said the first phase of its U.S. commercial launch has begun and that it believes the product will transform the way nitric oxide is used in hospitals.
The company expects to receive a CE Mark in Europe during the second half of the year.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.